PreveCeutical Medical Inc. PREV
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -391.10K | -394.60K | 926.90K | -623.00K | -877.50K |
| Total Depreciation and Amortization | 3.00K | 3.00K | 2.60K | 2.60K | 2.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.20K | 132.40K | -1.47M | 87.80K | 410.20K |
| Change in Net Operating Assets | 59.30K | 59.80K | 157.90K | 154.70K | 59.20K |
| Cash from Operations | -197.60K | -199.30K | -383.30K | -377.90K | -405.20K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -2.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1.80K | 39.60K | 300.00 |
| Cash from Investing | -- | -- | 1.80K | 39.60K | -1.80K |
| Total Debt Issued | 500.00 | 500.00 | 70.90K | -- | -58.90K |
| Total Debt Repaid | -- | -- | -74.70K | -30.70K | -67.30K |
| Issuance of Common Stock | 280.70K | 280.70K | 418.60K | 622.90K | 688.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 203.20K | 205.00K | 297.60K | 430.00K | 406.40K |
| Foreign Exchange rate Adjustments | 3.60K | 3.60K | 16.90K | -19.50K | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.20K | 9.30K | -67.00K | 72.20K | -900.00 |